Grant Pickering plans sale of 18,198 PCVX shares

Grant Pickering plans to sell up to 18,198 shares of common stock of PCVX through UBS Financial Services on or about 07/27/2026, with an aggregate market value of $996,704.46.

Rhea-AI Filing Summary

Grant Pickering plans to sell up to 18,198 shares of common stock of PCVX through UBS Financial Services on or about 07/27/2026, with an aggregate market value of $996,704.46. The planned sale includes 16,198 shares from an exercise of stock options and 2,000 founder shares. Recent sales over the prior three months are also listed for Pickering and two 2020 Delaware trusts associated with Claire and Benjamin Pickering, showing multiple transactions in June 2026 with specified share counts and total sale prices.

Key Figures

Shares planned for sale: 18,198 shares Aggregate market value of planned sale: $996,704.46 Shares from stock option exercise: 16,198 shares +3 more

6 metrics

Shares planned for sale 18,198 shares Common stock to be sold on or about 07/27/2026

Aggregate market value of planned sale $996,704.46 Value of 18,198 common shares to be sold

Shares from stock option exercise 16,198 shares Portion of planned sale tied to exercise of stock options

Founder shares in planned sale 2,000 shares Founder shares dated 12/09/2013 included in sale

Sale by Grant Pickering on 06/18/2026 22,461 shares for $1,179,204.75 Common stock sold during past 3 months

Sale by Grant Pickering on 06/26/2026 22,237 shares for $1,227,807.06 Common stock sold during past 3 months

Key Terms

Exercise of Stock Options, Founder Shares, Delaware Trust, Aggregate market value

4 terms

Exercise of Stock Options financial

"Common | 07/27/2026 | Exercise of Stock Options | Issuer"

Founder Shares financial

"Common | 12/09/2013 | Founder Shares | Issuer"

Founder shares are the ownership stakes given to the people who start a company, often with extra voting power or protections compared with ordinary shares. For investors, they matter because founders’ control and incentives influence decisions about strategy, hiring, and whether the company sells or stays independent — like a family that keeps majority voting rights in a household decision. High founder ownership can mean stable leadership but also a risk that outside shareholders have less influence.

Delaware Trust regulatory

"The Claire Pickering 2020 Delaware Trust 825 INDUSTRIAL ROAD"

Aggregate market value financial

"18198 | 996704.46 | 144397682 | 07/27/2026 | NASDAQ"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many PCVX shares does Grant Pickering plan to sell under this Form 144?

Grant Pickering plans to sell up to 18,198 shares of PCVX common stock. The planned transaction is valued at an aggregate $996,704.46 and is expected to occur on or about 07/27/2026 through UBS Financial Services.

What types of PCVX shares are included in Grant Pickering’s planned 18,198-share sale?

The 18,198 planned shares include 16,198 shares issuable from an exercise of stock options and 2,000 founder shares. The founder shares are dated 12/09/2013, reflecting an earlier equity grant now being registered for potential sale.

What recent PCVX share sales has Grant Pickering reported in the past three months?

Grant Pickering sold 22,461 shares of PCVX common stock for $1,179,204.75 on 06/18/2026 and 22,237 shares for $1,227,807.06 on 06/26/2026. These transactions are reported as securities sold during the past three months.

What PCVX sales have the Claire and Benjamin Pickering 2020 Delaware Trusts reported?

The Claire Pickering 2020 Delaware Trust sold 1,000 shares for $52,500.00 on 06/18/2026 and 1,000 shares for $55,259.30 on 06/26/2026. The Benjamin Pickering 2020 Delaware Trust sold 1,000 shares for $52,500.00 and 1,000 shares for $55,206.20 on the same dates.

Who is the broker for the planned PCVX share sale by Grant Pickering?

The planned sale of 18,198 PCVX common shares will be handled through UBS Financial Services, Inc. at 11 Madison Avenue, New York. The planned sale date is listed as 07/27/2026 and the shares are noted as trading on NASDAQ.

How is the planned PCVX sale under Form 144 related to stock options?

Of the 18,198 PCVX shares covered, 16,198 shares are tied to an exercise of stock options dated 07/27/2026. The remaining 2,000 shares are identified as founder shares originally dated 12/09/2013, indicating different origins for the securities.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 07/27/2026 - 04:17 PM Accepted by SEC EDGAR 07/27/2026 - 04:17 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001258693
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Vaxcyte, Inc.
SEC File Number	001-39323
Address of Issuer	825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CALIFORNIA 94070
Phone	650-837-0111
Name of Person for Whose Account the Securities are To Be Sold	PICKERING GRANT
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services, Inc. 11 Madison Ave 4th Floor New York NY 10010	18198	996704.46	144397682	07/27/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/27/2026	Exercise of Stock Options	Issuer			16198	07/27/2026	NA
Common	12/09/2013	Founder Shares	Issuer			2000	12/09/2013	NA

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Grant Pickering 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070	Common	06/18/2026	22461	1179204.75
The Claire Pickering 2020 Delaware Trust 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070	Common	06/18/2026	1000	52500.00
The Benjamin Pickering 2020 Delaware Trust 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070	Common	06/18/2026	1000	52500.00
Grant Pickering 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070	Common	06/26/2026	22237	1227807.06
The Claire Pickering 2020 Delaware Trust 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070	Common	06/26/2026	1000	55259.30
The Benjamin Pickering 2020 Delaware Trust 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070	Common	06/26/2026	1000	55206.20

144: Remarks and Signature

Remarks	16,198 shares represented in this filing are being sold under Grant Pickering, 1,000 shares are being sold under the Claire Pickering 2020 Delaware Trust and 1,000 shares are being sold under the Benjamin Pickering 2020Delaware Trust.
Date of Notice	07/27/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/03/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ UBS Financial Services Inc, as attorney-in-fact for Grant Pickering
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)